Statistics in the pharmaceutical industry
Author(s)
Bibliographic Information
Statistics in the pharmaceutical industry
(Statistics : textbooks and monographs, v. 140)
Marcel Dekker, c1994
2nd ed., rev. and expanded
Available at 13 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
-
Research Institute for Economics & Business Administration (RIEB) Library , Kobe University図書
615-1-2s081000088810*
Note
Includes bibliographical references and index
Description and Table of Contents
Description
This rewritten and updated second edition provides comprehensive information on the wide-ranging applications of statistics in the pharmacological field. Focusing on practical aspects, it sets out to bridge the gap between industry and academia.;Reflecting the changes that have taken place since publication of the first edition, this volume covers new topics such as: cancer clinical trials, clinical trials of AIDS patients and animal tumorigenicity studies; the development of antiepileptic drugs; the role of epidemiology in postmarketing trials and adverse drug experience; computer-assisted new drug application (CANDA) submissions; contract research organizations; interim analysis in clinical trials; and room-temperature tests for the stability of drugs.;This work is intended as: a reference for statisticians, biostatisticians, pharmacologists, administrators, managers, and scientists in the pharmaceutical industry; and a text for graduate students taking courses in applied statistics or pharmaceutical statistics.
Table of Contents
- Introduction to the evolution of pharmaceutical products
- statistical review and evaluation of animal tumorigenicity studies
- uses of bioassay in drug development - dose-response relationships
- the FDA and the IND/NDA statistical review process
- clinical trial designs
- selecting patients for clinical trial
- statistical aspects of cancer clinical trials
- antiepileptic drug development program - a collaboration of government and industry
- design and analysis of clinical trials of analgesic drugs
- crossover designs in medical research
- statistical considerations in clinical trials of AIDS patients
- bioavailability studies
- the wonders of placebo
- interim analysis
- postmarketing studies and adverse drug experiences - the role of epidemiology
- the role of contract research organizations in clinical research in the pharmaceutical industry
- documenting the results of a clinical study
- data quality assurance
- managing CANDA submissions in the 1990s
- quality control
- stability of drugs
- when and how to do multiple comparisons
- adjustment of P-values for multiplicities of intercorrelating symptoms
- screening compounds for clinically active drugs
- survey of statisticians in the pharmaceutical industry.
by "Nielsen BookData"